PRODIGE 98 : Randomized, Multicenter Phase 3 Trial of Adjuvant Chemotherapy With Modified FOLFIRINOX Versus Capecitabine or Gemcitabine in Patients With Resected Ampullary Adenocarcinoma
Clinical trial NCT06813976 · RECRUITING
Trial details
- NCT number
- NCT06813976
- Sponsor
- Centre Hospitalier Universitaire Dijon
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-02
- Primary completion
- 2033-07-01
- Enrollment
- 294
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.